About this event
Galderma is proud to own a portfolio of neuromodulators. In this webinar, they will be unlocking the science behind the award-winning, first liquid neuromodulator in Europe, Alluzience with the most recent clinical studies in addition to sharing over 12 months-experience of healthcare practitioners from UK.
Speaker:
Catharine Denning & Michelle Mclean Park
Please note: this webinar is for HCPs only. Non-HCPs will not be able to watch the webinar.
GB-ALZ-2400022 DOP April 2024
Hosted by
Michelle Mclean Park is a Nurse Independent Practitioner with 14 years in the Aesthetic Industry. With over 35,000 injectable procedures to date she is very experienced and leads one of the most successful clinics in Scotland. With a passion for the highest standards of patient care she is fully committed to helping the industry as a whole
Dr Catharine Denning is an aesthetic doctor with 10 years’ experience who specializes in injectable treatments. She runs busy clinics in Marylebone and Kent and is a trainer, global speaker and key thought leader for Galderma.
